During the past decade, MS and Neuromuscular Center of Excellence conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MS and Neuromuscular Center of Excellence" are "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "MS and Neuromuscular Center of Excellence" in a lesser frequency.

Most popular intervention types in "MS and Neuromuscular Center of Excellence" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Antihistamine" (1 trials), "Methylprednisolone" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "MS and Neuromuscular Center of Excellence" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MS and Neuromuscular Center of Excellence". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MS and Neuromuscular Center of Excellence, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MS and Neuromuscular Center of Excellence, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".